[6-K] NewGenIvf Group Ltd Current Report (Foreign Issuer)

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

NewGenIvf Group Limited announced a share repurchase program of up to US$2 million, as indicated in Exhibit 99.1 to a Form 6-K filing. Share repurchases can support shareholder value by decreasing the number of shares available in the market over time. The filing lists the program amount but does not include additional terms in this excerpt.

Insights

NewGenIvf authorized up to US$2 million in buybacks.

NewGenIvf Group Limited disclosed a share repurchase program authorizing purchases of up to US$2 million. Such programs permit the company to buy its own shares in the open market or through other methods as determined by company policy and applicable regulations.

The potential impact on per‑share metrics depends on the amount and pace of repurchases relative to trading liquidity and market conditions. Execution details and timing were not included in the provided excerpt.

11/10/2025 - 08:30 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-42004

NEWGENIVF GROUP LIMITED

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXHBIT INDEX

Exhibit No.		Description
99.1		NewGen Announces Up To US$2 Million Share Repurchase Program

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 10, 2025